Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent c
Det aktuella priset för LAB.F är €196 EUR — det har ökat med +0% under de senaste 24 timmarna. Följ Laboratory Of America-aktiens utveckling närmare i diagrammet.
Vad är Laboratory Of Americas aktiesymbol?▼
Beroende på börsen kan aktiesymbolen variera. Till exempel handlas Laboratory Of America-aktien på börsen under symbolen LAB.F.
Vad är Laboratory Of Americas börsvärde?▼
Idag har Laboratory Of America ett börsvärde på 16.15B
Vad var Laboratory Of Americas intäkter förra året?▼
Laboratory Of Americas intäkter för det senaste året uppgår till -8.07B EUR.
Vad var Laboratory Of Americas nettoresultat förra året?▼
LAB.Fs nettovinst för det senaste året är -517.31M EUR.
Betalar Laboratory Of America utdelningar?▼
Ja, LAB.F betalar utdelning kvartalsvis. Den senaste utdelningen per aktie var 0.66 EUR. I dag är utdelningsavkastningen (FWD)% 1.27%.
Hur många anställda har Laboratory Of America?▼
Från och med april 01, 2026 har företaget 67,000 anställda.
I vilken sektor finns Laboratory Of America?▼
Laboratory Of America verkar inom sektorn Healthcare.
När genomförde Laboratory Of America en aktiesplit?▼
Laboratory Of America har inte haft några splitar nyligen.
Var ligger Laboratory Of Americas huvudkontor?▼
Laboratory Of America har sitt huvudkontor i Burlington, US.